DLEU2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.68220992691204E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.29879995647286E-09 |
Normal-vs-Stage2 |
1.88300000003583E-06 |
Normal-vs-Stage3 |
1.39189992864885E-10 |
Normal-vs-Stage4 |
2.13640216628619E-12 |
Stage1-vs-Stage2 |
9.877500E-02 |
Stage1-vs-Stage3 |
1.977960E-02 |
Stage1-vs-Stage4 |
4.389200E-04 |
Stage2-vs-Stage3 |
9.549000E-01 |
Stage2-vs-Stage4 |
4.984400E-01 |
Stage3-vs-Stage4 |
3.405000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.72439840184779E-12 |
Normal-vs-AfricanAmerican |
4.02600000004583E-08 |
Normal-vs-Asian |
1.286430E-01 |
Caucasian-vs-AfricanAmerican |
3.746800E-01 |
Caucasian-vs-Asian |
4.134400E-01 |
AfricanAmerican-vs-Asian |
3.675000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.3603562720732E-12 |
Normal-vs-Female |
2.75446332409501E-13 |
Male-vs-Female |
3.605200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.717400E-03 |
Normal-vs-Age(41-60Yrs) |
3.84130505182156E-11 |
Normal-vs-Age(61-80Yrs) |
4.09483558172496E-12 |
Normal-vs-Age(81-100Yrs) |
6.63099997133543E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.742200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.028400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.005000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.373600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.800000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.962430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.68948000000002E-05 |
Normal-vs-Grade 2 |
1.58419943829813E-11 |
Normal-vs-Grade 3 |
3.22153415055482E-12 |
Normal-vs-Grade 4 |
9.01059999947051E-08 |
Grade 1-vs-Grade 2 |
3.977000E-01 |
Grade 1-vs-Grade 3 |
2.563800E-01 |
Grade 1-vs-Grade 4 |
7.150500E-02 |
Grade 2-vs-Grade 3 |
7.302600E-01 |
Grade 2-vs-Grade 4 |
1.679020E-01 |
Grade 3-vs-Grade 4 |
2.180000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.67157432129761E-12 |
Normal-vs-ccB subtype |
3.71709996116465E-09 |
ccA subtype-vs-ccB subtype |
8.518400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.05269135022945E-12 |
Normal-vs-N1 |
7.227400E-04 |
N0-vs-N1 |
6.463600E-01 |
|
|